People living in small-scale residential facilities vaccinated sooner by deploying Moderna as well as Pfizer/BioNTech Starting next week, vaccination for clients receiving care under the Long-Term Care Act, who are living in small-scale residential facilities without an institutional physician, will be expanded to the Pfizer/BioNTech vaccine and Moderna vaccine.
Lareb notes newly reported deaths shortly after vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
80 to 84-year-olds invited for vaccination sooner Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.
Publication WHO Good Practice Brief RIVM Centre for Healthy Living The Good Practice Brief 'Centre for Healthy Living in the Netherlands: Building sustainable capacity and alliances for effective health promotion' has been published on the World Health Organ
Fewer TB patients in the Netherlands The key figures of the National Institute for Public Health and the Environment (RIVM) show that in 2017, the number of TB patients in the Netherlands fell below 800 TB patients for the first time
Hormone-disrupting effect methyl-, ethyl- and propylparaben still unclear RIVM has conducted literature research into the hormone-disrupting effects of the three most commonly used parabens (methyl-, ethyl- and propylparaben) and the exposure of consumers to these substa